Clinica's New Stock Tracker - featured stock: Genoptix
This article was originally published in Clinica
Stock Highlight: Genoptix (GXDX) +105% The current turbulent global financial markets have sent medtech shares yo-yoing during the first few months of 2008. Financial uncertainty has resulted in the postponement of many IPOs, including that of French ophthalmic equipment specialist Luneau Technology, which cancelled its IPO on the Euronext's Alternext market on January 29.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.